EO Sterilization Validation - Sterility Testing and Load Configuration

htcoztrk

Starting to get Involved
#1
Hello to all!

I searched the forum to see if this thread already been opened but couldn't find any. If it was already opened, I apologize in advance.

I just started to work in a medical device manufacturer of products to be sterilized by EO gas and they -we- are validating the EO sterilization process which I have very limited experience with. So I already prepared the protocol based on EN ISO 11135 and some guidances however there are two points that I am not very sure:

1) Product sterility testing: So the SAL is determined as 10^-6 and we will use biological indicator containing Bacillus atrophaeus spores. We will perform 1 fractional (to see the recovery), 3 half cycles and 2 full cycles. BIs will be incubated and tested for sterility after each cycle. Sterility of actual products on loads to be performed after half cycle. However after which half cycle should we tested the product sterility and on what basis? Or sterility of products need to be tested after every half cycle? But in this case it is a huge money burden for the company. I checked the old records but it was too complicated for me to understand. So any help to clarify at which point should be perform the product sterility will be very appreciated.

2) Worst case configuration: We will use the mixed load during validation studies and already determined the worst case based on mass, density, packaging, shape and etc. of products. However I am not sure how does the loading configuration of mixed load into the sterilizer affect the validation. In case we demonstrate that all points inside the sterilizer are within the specified parameters (by performing physical validation simultaneously), does it matter where we put the loads during validation study and routine sterilization?

-Hatice
 
Elsmar Forum Sponsor

planB

Super Moderator
#2
htcoztrk,

I presume you are following the overkill half-cycle approach in validation your cycle (State your validation approach somewhere explicitly in your protocol):

ad (1): Product sterility testing is most critical and important to be performed on sample that have been subjected to sub-lethal (fractional) cycles. These cycles are intended to demonstrate that your product bioburden is easier to kill than your challenge organism. Therefore, you aim at the following result in sub-lethal runs: sterile product, some survivors on your PCD (process challenge device).

Once you have demonstrated this, you preferably perform sterility testing on products also during half cycles, confirming the results of your sub-lethal runs, but you do not necessarily have to in all half-cycle runs. More important is the demonstration of complete inactivation of your PCD in orer to show that you achieve the required SAL of 10^(-6).

Cost: microbiological tests are typically not expensive - residuals testing will cost you much more per sample

ad (2) Load variations might affect both lethality (i.e. cycle effectiveness) and sterilisation residuals (i.e. cycle safety), since the load has an impact on the critical parameters EO concentration, temperature (distribution), and humidity (distribution). You might consider performing a bracketed validation, having a minimum and a maximum (worst-case) load in half cycles and thus demonstrating that the load configuration has no impact on the SAL. You should map these half cycles in order to generate evidence of the uniformity of physical data that you are talking about as part of your PPQ activities. In this way you can partially combine MPQ and PPQ runs.

In terms of residuals, you will have to generate a full-cycle worst-case exposing your products to the maximum amount of EO and potentially even introduce a challenge to aeration. Note that a maximum load may absorb EO and thus, may not represent the worst case in terms of residuals.

HTH,

Gerhard
 
#3
Thanks Gerhard for taking the time to explain the answers. However, I had a follow-up question: What if during the fractional cycle, product sterility was achieved i.e NO growth on any of the products whereas ALL the BI samples showed growth (PCD).

Is that still valid (since it clearly shows that PCD is more resistant than the product bioburden) or should the fractional cycle be repeated to ensure partial kill of PCD (some of the BI samples show growth whereas others remain sterile)? If the fractional cycle has to be repeated, then in that case, for what purpose(s) is the partial kill of BI (and product sterility) necessary?

Note that the overkill half-cycle approach is used during this procedure. Since adequacy of recovery can be shown through the presence of growth in ALL BI samples, is it necessary to have partial kill of PCD in this step (some are survivors whereas others show growth)?
 

planB

Super Moderator
#4
What if during the fractional cycle, product sterility was achieved i.e NO growth on any of the products whereas ALL the BI samples showed growth (PCD). Is that still valid [...]?
Yes.

[...] is it necessary to have partial kill of PCD in this step [...]?
No.

Just take care that you do not employ an overly resistant/challenging PCD that may require you to design an overly lethal cycle.

HTH,
 
Thread starter Similar threads Forum Replies Date
B IPCD Sterility test failure during MPQ (EO sterilization validation) ISO 13485:2016 - Medical Device Quality Management Systems 2
N Sterilization Protocol Change in Validation Process and further impacts ISO 13485:2016 - Medical Device Quality Management Systems 1
S Sterilization validation after changing sterilization process provider Qualification and Validation (including 21 CFR Part 11) 3
B Sterilization Validation Plan Other Medical Device Related Standards 3
A Reprocessing, Cleaning, Disinfection and Sterilization Validation EU Medical Device Regulations 4
G Pyrogen Test - Sterilization Validation - MDR 2017/745 Other ISO and International Standards and European Regulations 6
F Irradiation Sterilization Validation Maximum Dose - VDmax 25 method (ISO 11137) EU Medical Device Regulations 2
E Ethylene Oxide Sterilization Validation-Reference Load Other Medical Device Related Standards 2
Q Use of parts in gamma sterilization validation - Reprocessing implants EU Medical Device Regulations 1
R ISO 11137 Gamma sterilization validation, dose setting, dose audit Other Medical Device Related Standards 1
S Requirement for Sterilization Validation completion before issuance of ISO cert ISO 13485:2016 - Medical Device Quality Management Systems 0
A Is Aeration Process in ETO Sterilization Validation Required? Manufacturing and Related Processes 7
B Product definition for Ethylene Oxide Sterilization Validation Other Medical Device Related Standards 2
K Re-validation of EtO sterilization after change of tape Other Medical Device and Orthopedic Related Topics 1
J Sterilization Validation Procedure Needed? ISO 13485:2016 - Medical Device Quality Management Systems 3
Sam Lazzara Ethylene Oxide Sterilization Validation question Other Medical Device Related Standards 13
L Regulatory Submittal During 3 Lot Sterilization Validation EU Medical Device Regulations 3
S Fractional cycle fail in Eto sterilization validation ISO 13485:2016 - Medical Device Quality Management Systems 3
L Steam Sterilization Validation per ANSI ST 79 Other Medical Device Related Standards 2
suildur Sterilization Validation of a Unique Medical Device Other Medical Device Related Standards 5
S Sterilization Validation Accreditation - A mandated standard requirement? ISO 13485:2016 - Medical Device Quality Management Systems 5
K Re-validation of Out Sourced Medical Device Sterilization Process ISO 13485:2016 - Medical Device Quality Management Systems 3
C Validation of Sterilization Procedures - ISO 13485 Section 7.5.2.2 Document Control Systems, Procedures, Forms and Templates 4
G Sterilization Re-Validation after Manufacturer Change Qualification and Validation (including 21 CFR Part 11) 17
Y 3rd Party Sterilization Validation for Reusable Medical Devices Other Medical Device Related Standards 7
S Steam Sterilization Validation Other Medical Device and Orthopedic Related Topics 4
T Missed Quarterly Dose Audit! Sterilization Validation of Medical Devices Other Medical Device and Orthopedic Related Topics 15
L Sterilization validation for reusable medical device class II Other Medical Device Related Standards 9
E Design for Sterilization Companies - The design of sterilization validation programs ISO 13485:2016 - Medical Device Quality Management Systems 12
M Sterilization Validation request for 510k 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 9
S Validation of Sterilization Expiry Date - Accelerated Aging, etc ISO 13485:2016 - Medical Device Quality Management Systems 6
S Gamma Sterilization Validation Documents - 13485:2003 section 7.5.1.2.1 ISO 13485:2016 - Medical Device Quality Management Systems 5
C Sterilization Validation ISO 14937 - Sterilizer that uses EO gas diffusion Qualification and Validation (including 21 CFR Part 11) 7
P ETO Sterilization Validation Process and an NCR - ISO 13485:2003 CMDCAS audit ISO 13485:2016 - Medical Device Quality Management Systems 1
K Iso 11135:1994 - Validation and Control of Ethylene Oxide Sterilization ISO 13485:2016 - Medical Device Quality Management Systems 5
validationspec LDPE for EO Sterilization ISO 13485:2016 - Medical Device Quality Management Systems 2
B Gamma Sterilization Other Medical Device Related Standards 1
C Non-sterile reusable surgical instruments - FDA sterilization requirement Other Medical Device Related Standards 2
chris1price Sterilization using beta radiation Other Medical Device Related Standards 2
A ISO 13485 Sterilization Clause Applicability ISO 13485:2016 - Medical Device Quality Management Systems 7
S Orthopedic Implants (Knee system) Sterilization Indicators Manufacturing and Related Processes 6
chris1price Contract Sterilization Service Providers ISO 13485:2016 - Medical Device Quality Management Systems 5
R Scientific Operating Procedures For Sterilization Practices in India PSA/2012/1 Other Medical Device Regulations World-Wide 0
N Looking for Gamma sterilization facility in China ISO 13485:2016 - Medical Device Quality Management Systems 4
I Release checklist EO sterilization process Medical Device and FDA Regulations and Standards News 6
MrTetris Are GLP required for testing cytotoxicity and soil remaining after sterilization of MD? Other Medical Device Related Standards 8
Z EN 868-8 "required tests" - Rigid sterilization containers Other Medical Device Related Standards 0
Judy Abbott Increase the maximum allowable dose for E-beam sterilization Reliability Analysis - Predictions, Testing and Standards 2
W EO sterilization and pallets Other Medical Device and Orthopedic Related Topics 4
M Informational Device Shortages Update – The US FDA Announces Two New Innovation Challenges on Device Sterilization Medical Device and FDA Regulations and Standards News 0

Similar threads

Top Bottom